Assess overall atopic dermatitis severity using the Investigator's Global Assessment (IGA) 5-point scale from 0 (clear) to 4 (severe), used as a regulatory endpoint for biologic and JAK inhibitor trials.
Enter the values for the scenario you are assessing. Assess overall atopic dermatitis severity using the Investigator's Global Assessment (IGA) 5-point scale from 0 (clear) to 4 (severe), used as a regulatory endpoint for biologic and JAK inhibitor trials. Use the iga eczema result to inform your calculation.